The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value chain, from research and development through to CMC, to accelerate the ...
New manufacturing technologies aim to accelerate next-generation cell therapy development Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies ...
AUSTIN, Texas--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug Administration (FDA) has ...
DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...
Human induced pluripotent stem cells (iPSCs) provide a novel platform for developing cell therapies targeting diseases, from rare genetic disorders to cancer, autoimmune diseases and regenerative ...
Astrocytes, critical players in the central nervous system (CNS), have long been overlooked in neurological research. In this interview, Dr. Mitzy Rios de Anda from bit.bio sheds light on the ...
New laws introduced by the federal government could see MPs fined, kicked off committees and even suspended. The laws will increase the consequences for politicians and members of staff who engage in ...
Autologous bone marrow transplant in standard-risk newly diagnosed multiple myeloma: A systematic review. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global Summit for Oncology ...
In this interview, we speak to Keith Olson and Coby Carlson from FUJIFILM Cellular Dynamics about their iPSC technology and how it is making breakthroughs in blood-brain barrier research. Please can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results